Ad
related to: merck+%26+co
Search results
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoJeito Capital announces the acquisition by Merck & Co (NYSE: MRK)of its portfolio company EyeBio for a potential value of $3 billion This acquisition reflects ...
Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly
Simply Wall St. via Yahoo Finance· 4 days agoWhen we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. We can see that Merck & Co.
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga· 2 days agoMonday, Moderna Inc MRNA and Merck & Co Inc MRK announced the first presentation of results from a planned analysis from the Phase 2b KEYNOTE-942/mRNA-4157 ...
Merck (MRK) to Buy Private Ophthalmology Company EyeBio
Zacks via Yahoo Finance· 6 days agoMerck's (MRK) acquisition of EyeBio is set to add the latter's lead pipeline candidate, Restoret, a...
Merck acquires EyeBio in up to $3B deal By Proactive Investors
Investing.com· 6 days agoMerck & Co Inc (NYSE:MRK, ETR:6MK) announced it is acquiring Eyebio, a privately held...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 2 days ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy...
What drug manufacturer Lonza plans to do with Genentech's soon-to-be-former Vacaville site - San...
The Business Journals· 8 hours agoThe deal, announced in March, remains in the process of regulatory approval, said Hyvert, who noted...
Summit Shares Soar After Cancer Drug Tops Merck’s Keytruda
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Summit Therapeutics Inc. shares jumped after the biotech company said a late-stage...
Merck to buy EyeBio in a deal that could valued at up to $3 billion
Morningstar· 7 days agoMerck & Co. Inc. (MRK) announced Wednesday an agreement to buy privately held Eyebiotech Ltd., an ophthalmology-focused biotechnology company, in a deal ...
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Market Watch· 5 days agojumped more than 270% Thursday after the company said its experimental cancer drug outperformed ...